About the Event
Email Keli Hawthorne for Zoom information.
By the end of this event series, the audience participant should be able to:
- Recognize the national model of clinical research supported by the Cystic Fibrosis Foundation that has resulted in dramatically improved health outcomes.
- Describe the mechanisms behind Cystic Fibrosis transmembrane conductance regulator (CFTR) modulator therapy.
- Identify new therapies beyond CFTR modulators currently under investigation.
- Primary: Physicians, Basic Scientists
- Secondary: Fellows, Residents, Medical Students, Nursing staff, Post-Docs, and other members of the health care team
This activity has been designed to promote some of the following desired physician attributes and competencies:
- ACGME: Patient Care; Medical Knowledge; Practice-based Learning & Improvement; Systems-based Practice
- IOM: Provide patient-centered care; Work in interdisciplinary teams; Use evidence-based practice; Apply quality improvement; Utilize informatics
- IECC: Values/Ethics for Interprofessional Practice; Roles/Responsibilities; Interprofessional communication; Interprofessional Teams and Teamwork
For more information, please contact Keli Hawthorne at email@example.com.
Fullmer, speaker for this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.
The following planners for this educational activity Z. Leah Harris, M.D.; Keli Hawthorne, M.S., R.D., and Juliet Laney do not have relevant financial relationship(s) with ineligible companies to disclose.
The University of Texas at Austin Dell Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Texas at Austin Dell Medical School designates this internet live course for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.